Cargando…

Birth outcome in women with breast cancer, cutaneous malignant melanoma, or Hodgkin’s disease: a review

BACKGROUND: Data on birth outcome in women diagnosed with cancer before, during, or shortly after pregnancy are very sparse. The purpose of this review was to summarize the existing epidemiologic evidence of the adverse effect of breast cancer, cutaneous malignant melanoma, and Hodgkin’s disease on...

Descripción completa

Detalles Bibliográficos
Autor principal: Langagergaard, Vivian
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3035602/
https://www.ncbi.nlm.nih.gov/pubmed/21326655
http://dx.doi.org/10.2147/CLEP.S12190
_version_ 1782197793596637184
author Langagergaard, Vivian
author_facet Langagergaard, Vivian
author_sort Langagergaard, Vivian
collection PubMed
description BACKGROUND: Data on birth outcome in women diagnosed with cancer before, during, or shortly after pregnancy are very sparse. The purpose of this review was to summarize the existing epidemiologic evidence of the adverse effect of breast cancer, cutaneous malignant melanoma, and Hodgkin’s disease on birth outcome. METHODS: The MEDLINE database was used to review the literature systematically. Studies that examined the following outcomes were included: preterm birth, low birth weight, low birth weight at term, stillbirths, congenital abnormalities, male proportion of newborns, and mean birth weight. Studies were grouped according to whether the woman had been diagnosed with the specific cancer before, during, or shortly after pregnancy. RESULTS: Few data exist on birth outcome in women with breast cancer, melanoma, or Hodgkin’s disease. The overall results from the limited number of studies, which included a comparison group for birth outcome, were reassuring. However, for women diagnosed with breast cancer before pregnancy, the only 2 studies that included comparison groups for birth outcome had conflicting results regarding the risk of preterm birth and congenital abnormalities. Furthermore, a recent cohort study of birth outcome in women who were diagnosed with Hodgkin’s disease before pregnancy indicated a slightly increased risk of congenital abnormalities among the newborns. CONCLUSION: Overall, the existing studies offer reassuring results concerning the risks of adverse birth outcome for women diagnosed with breast cancer, melanoma, or Hodgkin’s disease before, during or shortly after pregnancy. A limitation of most studies was the imprecise risk estimates caused by the small number of adverse birth outcomes and the lack of results stratified by treatment. Therefore, international collaboration is necessary in the future, to obtain more precise risk estimates for adverse birth outcomes, and to allow stratified analyses according to, for example, treatment.
format Text
id pubmed-3035602
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-30356022011-02-16 Birth outcome in women with breast cancer, cutaneous malignant melanoma, or Hodgkin’s disease: a review Langagergaard, Vivian Clin Epidemiol Review BACKGROUND: Data on birth outcome in women diagnosed with cancer before, during, or shortly after pregnancy are very sparse. The purpose of this review was to summarize the existing epidemiologic evidence of the adverse effect of breast cancer, cutaneous malignant melanoma, and Hodgkin’s disease on birth outcome. METHODS: The MEDLINE database was used to review the literature systematically. Studies that examined the following outcomes were included: preterm birth, low birth weight, low birth weight at term, stillbirths, congenital abnormalities, male proportion of newborns, and mean birth weight. Studies were grouped according to whether the woman had been diagnosed with the specific cancer before, during, or shortly after pregnancy. RESULTS: Few data exist on birth outcome in women with breast cancer, melanoma, or Hodgkin’s disease. The overall results from the limited number of studies, which included a comparison group for birth outcome, were reassuring. However, for women diagnosed with breast cancer before pregnancy, the only 2 studies that included comparison groups for birth outcome had conflicting results regarding the risk of preterm birth and congenital abnormalities. Furthermore, a recent cohort study of birth outcome in women who were diagnosed with Hodgkin’s disease before pregnancy indicated a slightly increased risk of congenital abnormalities among the newborns. CONCLUSION: Overall, the existing studies offer reassuring results concerning the risks of adverse birth outcome for women diagnosed with breast cancer, melanoma, or Hodgkin’s disease before, during or shortly after pregnancy. A limitation of most studies was the imprecise risk estimates caused by the small number of adverse birth outcomes and the lack of results stratified by treatment. Therefore, international collaboration is necessary in the future, to obtain more precise risk estimates for adverse birth outcomes, and to allow stratified analyses according to, for example, treatment. Dove Medical Press 2010-12-23 /pmc/articles/PMC3035602/ /pubmed/21326655 http://dx.doi.org/10.2147/CLEP.S12190 Text en © 2011 Langagergaard, publisher and licensee Dove Medical Press Ltd. This is an Open Access article which permits unrestricted noncommercial use, provided the original work is properly cited.
spellingShingle Review
Langagergaard, Vivian
Birth outcome in women with breast cancer, cutaneous malignant melanoma, or Hodgkin’s disease: a review
title Birth outcome in women with breast cancer, cutaneous malignant melanoma, or Hodgkin’s disease: a review
title_full Birth outcome in women with breast cancer, cutaneous malignant melanoma, or Hodgkin’s disease: a review
title_fullStr Birth outcome in women with breast cancer, cutaneous malignant melanoma, or Hodgkin’s disease: a review
title_full_unstemmed Birth outcome in women with breast cancer, cutaneous malignant melanoma, or Hodgkin’s disease: a review
title_short Birth outcome in women with breast cancer, cutaneous malignant melanoma, or Hodgkin’s disease: a review
title_sort birth outcome in women with breast cancer, cutaneous malignant melanoma, or hodgkin’s disease: a review
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3035602/
https://www.ncbi.nlm.nih.gov/pubmed/21326655
http://dx.doi.org/10.2147/CLEP.S12190
work_keys_str_mv AT langagergaardvivian birthoutcomeinwomenwithbreastcancercutaneousmalignantmelanomaorhodgkinsdiseaseareview